Constitutive activation of Epstein-Barr virus (EBV) nuclear antigen 1 gene transcription by IRF1 and IRF2 during restricted EBV latency.
about
IRF7: activation, regulation, modification and functionThe A20 deubiquitinase activity negatively regulates LMP1 activation of IRF7IRF-7, a new interferon regulatory factor associated with Epstein-Barr virus latencyRNA-Mediated Regulation of HMGA1 FunctionIdentification of novel co-repressor molecules for Interferon Regulatory Factor-2Epstein-Barr virus latency switch in human B-cells: a physico-chemical model.Mechanisms that regulate Epstein-Barr virus EBNA-1 gene transcription during restricted latency are conserved among lymphocryptoviruses of Old World primates.Interferon regulatory factor 1 restricts gammaherpesvirus replication in primary immune cells.The Epstein-Barr virus major latent promoter Qp is constitutively active, hypomethylated, and methylation sensitiveAn interferon regulatory factor binding site in the U5 region of the bovine leukemia virus long terminal repeat stimulates Tax-independent gene expressionInterferon regulatory factor 7 is induced by Epstein-Barr virus latent membrane protein 1Repression of Epstein-Barr virus EBNA-1 gene transcription by pRb during restricted latencyProtein-DNA binding and CpG methylation at nucleotide resolution of latency-associated promoters Qp, Cp, and LMP1p of Epstein-Barr virusInterferon regulatory factor 2 represses the Epstein-Barr virus BamHI Q latency promoter in type III latency.Viral latency and its regulation: lessons from the gamma-herpesviruses.Use of differential display reverse transcription-PCR to reveal cellular changes during stimuli that result in herpes simplex virus type 1 reactivation from latency: upregulation of immediate-early cellular response genes TIS7, interferon, and interA gammaherpesvirus cooperates with interferon-alpha/beta-induced IRF2 to halt viral replication, control reactivation, and minimize host lethality.Molecular virology of Epstein-Barr virus.miR-23a targets interferon regulatory factor 1 and modulates cellular proliferation and paclitaxel-induced apoptosis in gastric adenocarcinoma cells.The Epstein-Barr virus latency BamHI-Q promoter is positively regulated by STATs and Zta interference with JAK/STAT activation leads to loss of BamHI-Q promoter activityInterferon-independent and -induced regulation of Epstein-Barr virus EBNA-1 gene transcription in Burkitt lymphoma.p48 (ISGF-3gamma) is involved in interferon-alpha-induced suppression of hepatitis B virus enhancer-1 activity.Interferon regulatory factor 4 is activated through c-Src-mediated tyrosine phosphorylation in virus-transformed cells.The Epstein-Barr virus-encoded LMP-1 oncoprotein negatively affects Tyk2 phosphorylation and interferon signaling in human B cells.Expression of EBNA-1 mRNA is regulated by cell cycle during Epstein-Barr virus type I latency.Cell-to-cell contact as an efficient mode of Epstein-Barr virus infection of diverse human epithelial cellsDifferential methylation of Epstein-Barr virus latency promoters facilitates viral persistence in healthy seropositive individuals.High-resolution analysis of CpG methylation and in vivo protein-DNA interactions at the alternative Epstein-Barr virus latency promoters Qp and Cp in the nasopharyngeal carcinoma cell line C666-1.An interferon-sensitive response element is involved in constitutive caspase-8 gene expression in neuroblastoma cells.Alternative EBNA1 expression in organ transplant patients.Lipopolysaccharide activates the expression of ISG15-specific protease UBP43 via interferon regulatory factor 3.Co-occupancy of the interferon regulatory element of the class II transactivator (CIITA) type IV promoter by interferon regulatory factors 1 and 2.Synergistic regulation of the human interleukin-12 p40 promoter by NFkappaB and Ets transcription factors in Epstein-Barr virus-transformed B cells and macrophages.Autorepression of Epstein-Barr virus nuclear antigen 1 expression by inhibition of pre-mRNA processing.The cell cycle control element of histone H4 gene transcription is maximally responsive to interferon regulatory factor pairs IRF-1/IRF-3 and IRF-1/IRF-7.Latency pattern of Epstein-Barr virus and methylation status in Epstein-Barr virus-associated hemophagocytic syndrome.Interferon regulatory factor 8 regulates caspase-1 expression to facilitate Epstein-Barr virus reactivation in response to B cell receptor stimulation and chemical induction.NF-κB Signaling Regulates Epstein-Barr Virus BamHI-Q-Driven EBNA1 Expression.
P2860
Q24299740-66AB0F63-DC34-4308-903C-4DDBA53AD915Q24306662-2569337E-8EFD-420C-B1F4-A9A5CA8D2F46Q24315695-C73E8896-E031-4350-8B7D-EF5AD2151ACEQ26820236-D7F55292-54E2-4CB3-8473-D41D7119C0AAQ28589914-581725DA-5EF9-4739-B511-7B961093CFCCQ33296308-38E94798-BDC9-46B7-A320-D52AF2DEEE52Q33653017-F52588D5-EE7D-4C27-AD37-1510D7BBCA7EQ33743822-7C508AB4-1A44-4D8E-A7B0-BE69FBFF3911Q33783746-CADB7681-967E-4A6E-AFA1-8982CAF67B96Q33784972-79F8EEF1-D931-489E-BE18-FE79A4BA814DQ33792860-8B004AF9-EBD0-42D3-8EA5-E3B90F43A6FBQ33818658-1A08D523-F644-420B-AA4A-92F2112384EDQ33865166-108B00E5-1613-4F63-A0E4-4AD06164E8ADQ33957851-116BE177-70BD-4035-8346-5553A28F85DAQ34039189-BF35A641-5F0A-4AED-BB5A-F4215F677416Q34069600-11F4C71B-DB59-4B90-A73B-C123606D3839Q34082662-5F49BFEC-186D-45C3-975F-F1B93D76AF3DQ34225554-1023C085-3869-4DB8-AA85-36EB743A912FQ34778619-66E8616C-8C87-44ED-9636-B22A426F09D9Q35603820-F5C49A9B-06A7-4A73-AEDD-5A49BE3EFF33Q35892261-BCA41C99-773C-472A-9EDA-F584AF8F4909Q38320298-010F2E1D-E17C-4F1E-9018-2684035E20BFQ39134387-90873401-FEE4-417B-A643-3326612993ABQ39321358-E6177F01-61C0-43C8-A7C5-93B9626AAE7AQ39549997-0F78372F-6321-4BED-9526-7459AE74864CQ39578660-2CA0831E-C64E-4AA8-9041-89B962B1BB41Q39596964-A4F30F16-0A3A-4FAB-9CF8-F01EF3A8D67AQ40131153-8DAE5BFD-0017-4A5A-8272-4D7E1BD8CF58Q40220978-4B631E28-BA58-4648-907B-FC88A5BC9925Q40420532-918E9BC0-6D57-4C1D-9702-47AEAB405293Q40749748-754CAC80-30B1-4E46-A45E-63013E84D92CQ40918858-C2926255-EE14-4EE7-A186-21E8021A1ED9Q41052237-4B0D5B10-A4A9-450A-9B53-E43DD9185C7CQ42244791-392A68C7-0D38-40D2-949F-4267BD591596Q42830551-E27F01B6-2B30-4001-B7AF-F2A2CC94313AQ43835388-06128F71-9280-4350-8800-3B41CAE7B5ADQ47550358-B06402A8-AAB2-4543-BAA6-F4BE91D9DF3AQ54115911-C35B48FB-34B0-405A-8670-3595A06CB62C
P2860
Constitutive activation of Epstein-Barr virus (EBV) nuclear antigen 1 gene transcription by IRF1 and IRF2 during restricted EBV latency.
description
1997 nî lūn-bûn
@nan
1997年の論文
@ja
1997年論文
@yue
1997年論文
@zh-hant
1997年論文
@zh-hk
1997年論文
@zh-mo
1997年論文
@zh-tw
1997年论文
@wuu
1997年论文
@zh
1997年论文
@zh-cn
name
Constitutive activation of Eps ...... during restricted EBV latency.
@en
type
label
Constitutive activation of Eps ...... during restricted EBV latency.
@en
prefLabel
Constitutive activation of Eps ...... during restricted EBV latency.
@en
P2093
P2860
P356
P1476
Constitutive activation of Eps ...... during restricted EBV latency.
@en
P2093
P2860
P304
P356
10.1128/MCB.17.2.873
P407
P577
1997-02-01T00:00:00Z